133 related articles for article (PubMed ID: 30268577)
1. Validation of a clinically-relevant rodent model of statin-associated muscle symptoms for use in pharmacological studies.
Irwin JC; Fenning AS; Ryan KR; Vella RK
Toxicol Appl Pharmacol; 2018 Dec; 360():78-87. PubMed ID: 30268577
[TBL] [Abstract][Full Text] [Related]
2. Structural and functional characterization of simvastatin-induced myotoxicity in different skeletal muscles.
Simsek Ozek N; Bal IB; Sara Y; Onur R; Severcan F
Biochim Biophys Acta; 2014 Jan; 1840(1):406-15. PubMed ID: 24045089
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological activation of the pyruvate dehydrogenase complex reduces statin-mediated upregulation of FOXO gene targets and protects against statin myopathy in rodents.
Mallinson JE; Constantin-Teodosiu D; Glaves PD; Martin EA; Davies WJ; Westwood FR; Sidaway JE; Greenhaff PL
J Physiol; 2012 Dec; 590(24):6389-402. PubMed ID: 23045346
[TBL] [Abstract][Full Text] [Related]
4. Geranylgeraniol prevents statin-induced skeletal muscle fatigue without causing adverse effects in cardiac or vascular smooth muscle performance.
Irwin JC; Fenning AS; Vella RK
Transl Res; 2020 Jan; 215():17-30. PubMed ID: 31491372
[TBL] [Abstract][Full Text] [Related]
5. Statins with different lipophilic indices exert distinct effects on skeletal, cardiac and vascular smooth muscle.
Irwin JC; Fenning AS; Vella RK
Life Sci; 2020 Feb; 242():117225. PubMed ID: 31881229
[TBL] [Abstract][Full Text] [Related]
6. Statin-Induced Increases in Atrophy Gene Expression Occur Independently of Changes in PGC1α Protein and Mitochondrial Content.
Goodman CA; Pol D; Zacharewicz E; Lee-Young RS; Snow RJ; Russell AP; McConell GK
PLoS One; 2015; 10(5):e0128398. PubMed ID: 26020641
[TBL] [Abstract][Full Text] [Related]
7. Statin-induced muscle necrosis in the rat: distribution, development, and fibre selectivity.
Westwood FR; Bigley A; Randall K; Marsden AM; Scott RC
Toxicol Pathol; 2005; 33(2):246-57. PubMed ID: 15902968
[TBL] [Abstract][Full Text] [Related]
8. Modeling statin myopathy in a human skeletal muscle microphysiological system.
Ananthakumar A; Liu Y; Fernandez CE; Truskey GA; Voora D
PLoS One; 2020; 15(11):e0242422. PubMed ID: 33237943
[TBL] [Abstract][Full Text] [Related]
9. Effects of myosin heavy chain (MHC) plasticity induced by HMGCoA-reductase inhibition on skeletal muscle functions.
Trapani L; Melli L; Segatto M; Trezza V; Campolongo P; Jozwiak A; Swiezewska E; Pucillo LP; Moreno S; Fanelli F; Linari M; Pallottini V
FASEB J; 2011 Nov; 25(11):4037-47. PubMed ID: 21798954
[TBL] [Abstract][Full Text] [Related]
10. The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI): Revision for Clinical Use, Content Validation, and Inter-rater Reliability.
Rosenson RS; Miller K; Bayliss M; Sanchez RJ; Baccara-Dinet MT; Chibedi-De-Roche D; Taylor B; Khan I; Manvelian G; White M; Jacobson TA
Cardiovasc Drugs Ther; 2017 Apr; 31(2):179-186. PubMed ID: 28421332
[TBL] [Abstract][Full Text] [Related]
11. Simvastatin monotherapy as a potential option for statin-associated muscle symptoms: a case report.
Qu H; Guo M; Kou N; Wu HT; Zhang Y; Gao ZY; Shi DZ
J Clin Pharm Ther; 2016 Oct; 41(5):568-71. PubMed ID: 27425755
[TBL] [Abstract][Full Text] [Related]
12. Mitophagy protects against statin-mediated skeletal muscle toxicity.
Ramesh M; Campos JC; Lee P; Song Y; Hernandez G; Sin J; Tucker KC; Saadaeijahromi H; Gurney M; Ferreira JCB; Andres AM
FASEB J; 2019 Nov; 33(11):11857-11869. PubMed ID: 31365836
[TBL] [Abstract][Full Text] [Related]
13. Low vitamin D does not predict statin associated muscle symptoms but is associated with transient increases in muscle damage and pain.
Taylor BA; Lorson L; White CM; Thompson PD
Atherosclerosis; 2017 Jan; 256():100-104. PubMed ID: 27993387
[TBL] [Abstract][Full Text] [Related]
14. Skeletal muscle mitochondrial capacity in patients with statin-associated muscle symptoms (SAMS).
Mangone LA; Taylor BA; Schmelzer R; Noh SG; White MC; Kwon OS; Thompson PD
Open Heart; 2024 Feb; 11(1):. PubMed ID: 38388189
[TBL] [Abstract][Full Text] [Related]
15. Effect of simvastatin on passive strain-induced skeletal muscle injury in rats.
Tomazoni SS; Leal-Junior EC; Pallotta RC; De Godoi V; Rossi RP; Frigo L; Leonardo PS; De Almeida P; Lopes-Martins RÁ
Muscle Nerve; 2012 Dec; 46(6):908-13. PubMed ID: 23042107
[TBL] [Abstract][Full Text] [Related]
16. Decreased ubiquinone availability and impaired mitochondrial cytochrome oxidase activity associated with statin treatment.
Duncan AJ; Hargreaves IP; Damian MS; Land JM; Heales SJ
Toxicol Mech Methods; 2009 Jan; 19(1):44-50. PubMed ID: 19778232
[TBL] [Abstract][Full Text] [Related]
17. Statin therapy induces ultrastructural damage in skeletal muscle in patients without myalgia.
Draeger A; Monastyrskaya K; Mohaupt M; Hoppeler H; Savolainen H; Allemann C; Babiychuk EB
J Pathol; 2006 Sep; 210(1):94-102. PubMed ID: 16799920
[TBL] [Abstract][Full Text] [Related]
18. Statins Affect Skeletal Muscle Performance: Evidence for Disturbances in Energy Metabolism.
Allard NAE; Schirris TJJ; Verheggen RJ; Russel FGM; Rodenburg RJ; Smeitink JAM; Thompson PD; Hopman MTE; Timmers S
J Clin Endocrinol Metab; 2018 Jan; 103(1):75-84. PubMed ID: 29040646
[TBL] [Abstract][Full Text] [Related]
19. Statin or fibrate chronic treatment modifies the proteomic profile of rat skeletal muscle.
Camerino GM; Pellegrino MA; Brocca L; Digennaro C; Camerino DC; Pierno S; Bottinelli R
Biochem Pharmacol; 2011 Apr; 81(8):1054-64. PubMed ID: 21300028
[TBL] [Abstract][Full Text] [Related]
20. Rationale for investigating metformin as a protectant against statin-associated muscle symptoms.
Elsaid O; Taylor B; Zaleski A; Panza G; Thompson PD
J Clin Lipidol; 2017; 11(5):1145-1151. PubMed ID: 28764958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
